By Abigail Townsend
Date: Wednesday 07 May 2025
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
Patent Woes Threaten Drug Firms | 07-Mar-2011 | New York Times |
Stocks push higher on deals and strong earnings | 09-Feb-2011 | USA Today |
Dow soars to close above 12,000 | 02-Feb-2011 | Wall Street Journal |
Pfizer To Close UK Plant And Axe 2,400 Jobs | 01-Feb-2011 | Sky News |
Despite good earnings reports, stocks tumble | 21-Oct-2009 | Wall Street Journal |
Currency | US Dollars |
Share Price | $ 23.32 |
Change Today | $ 0.28 |
% Change | 1.22 % |
52 Week High | $31.39 |
52 Week Low | $21.59 |
Volume | 35,405,386 |
Shares Issued | 5,667m |
Market Cap | $132,154m |
Beta | 0.45 |
RiskGrade | 102 |
Strong Buy | 3 |
Buy | 4 |
Neutral | 15 |
Sell | 0 |
Strong Sell | 1 |
Total | 23 |
Time | Volume / Share Price |
16:00 | 4,094,895 @ $23.32 |
15:59 | 200 @ $23.33 |
15:59 | 100 @ $23.33 |
15:59 | 1,000 @ $23.33 |
15:59 | 800 @ $23.33 |
You are here: research